Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald R Mattison

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Journal of Biomedicine & Biotechnology|March 16, 2011
Sex differences in drug dispositionOffie P Soldin, Sarah H Chung, Donald R Mattison
BMJ (Clinical Research Ed.)|July 25, 2014
Dabigatran, bleeding, and the regulatorsThomas J Moore, Michael R Cohen, Donald R Mattison
International Journal of Pediatric Endocrinology|January 30, 2010
A categorical structure-activity relationship analysis of the developmental toxicity of antithyroid drugsAlbert R Cunningham, C Alex Carrasquer, Donald R Mattison
Critical Reviews in Toxicology|August 8, 2014
Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gapsDonald R Mattison, Nataliya Karyakina, Michael Goodman, et al.
Critical Reviews in Toxicology|August 18, 2017
Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and futureMelissa A Davidson, Donald R Mattison, Laurent Azoulay, et al.
Journal of Toxicology and Environmental Health. Part B, Critical Reviews|July 10, 2015
Improving Concordance in Environmental Epidemiology: A Three-Part ProposalJudy S LaKind, Michael Goodman, Susan L Makris, et al.
Pharmacotherapy|June 6, 2022
Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary reviewThomas J Moore, Abdallah Alami, G Caleb Alexander, et al.
British Journal of Clinical Pharmacology|March 13, 2023
Concomitant use of statins and sodium-glucose co-transporter 2 inhibitors and the risk of myotoxicity reporting: A disproportionality analysisChristopher A Gravel, Daniel Krewski, Donald R Mattison, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|October 7, 2008
Environmental exposures and adverse pregnancy outcomes: a review of the scienceKaren Perry Stillerman, Donald R Mattison, Linda C Giudice, et al.
American Journal of Obstetrics and Gynecology|October 16, 2007
Human decidual cell Toll-like receptor signaling in response to endotoxin: the effect of progestinsHyagriv N Simhan, Jye-Ping Chiao, Donald R Mattison, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Journal of Biomedicine & Biotechnology|March 16, 2011
Sex differences in drug dispositionOffie P Soldin, Sarah H Chung, Donald R Mattison
BMJ (Clinical Research Ed.)|July 25, 2014
Dabigatran, bleeding, and the regulatorsThomas J Moore, Michael R Cohen, Donald R Mattison
International Journal of Pediatric Endocrinology|January 30, 2010
A categorical structure-activity relationship analysis of the developmental toxicity of antithyroid drugsAlbert R Cunningham, C Alex Carrasquer, Donald R Mattison
Critical Reviews in Toxicology|August 8, 2014
Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gapsDonald R Mattison, Nataliya Karyakina, Michael Goodman, et al.
Critical Reviews in Toxicology|August 18, 2017
Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and futureMelissa A Davidson, Donald R Mattison, Laurent Azoulay, et al.
Journal of Toxicology and Environmental Health. Part B, Critical Reviews|July 10, 2015
Improving Concordance in Environmental Epidemiology: A Three-Part ProposalJudy S LaKind, Michael Goodman, Susan L Makris, et al.
Pharmacotherapy|June 6, 2022
Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary reviewThomas J Moore, Abdallah Alami, G Caleb Alexander, et al.
British Journal of Clinical Pharmacology|March 13, 2023
Concomitant use of statins and sodium-glucose co-transporter 2 inhibitors and the risk of myotoxicity reporting: A disproportionality analysisChristopher A Gravel, Daniel Krewski, Donald R Mattison, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|October 7, 2008
Environmental exposures and adverse pregnancy outcomes: a review of the scienceKaren Perry Stillerman, Donald R Mattison, Linda C Giudice, et al.
American Journal of Obstetrics and Gynecology|October 16, 2007
Human decidual cell Toll-like receptor signaling in response to endotoxin: the effect of progestinsHyagriv N Simhan, Jye-Ping Chiao, Donald R Mattison, et al.
Pageof 9